Cargando…

HBME-1 expression in differentiated thyroid carcinoma and its correlation with the ultrasonic manifestation of thyroid

We investigated expression of the protein human bone marrow endothelial cell marker-1 (HBME-1) in differentiated thyroid carcinoma tissues, and analyzed its correlation with ultrasonic manifestation of thyroid. The immunohistochemistry (IHC) staining method was used to measure the expression of HBME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiao, Jiwei, Li, Chunyu, Zhang, Yuying, Wang, Shuangyan, Gao, Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678245/ https://www.ncbi.nlm.nih.gov/pubmed/29151906 http://dx.doi.org/10.3892/ol.2017.6971

Ejemplares similares

CD56, HBME-1 and cytokeratin 19 expressions in papillary thyroid carcinoma and nodular thyroid lesions
por: Erdogan-Durmus, Senay, et al.
Publicado: (2016)

Immunohistochemical Expression of HBME-1 and TROP-2 in Some Follicular-Derived Thyroid Lesions
por: Abu-Seadah, Shimaa Shafik, et al.
Publicado: (2023)

Expression of ck-19, galectin-3 and hbme-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis
por: de Matos, Leandro Luongo, et al.
Publicado: (2012)

Immunoexpression of HBME-1, High Molecular Weight Cytokeratin, Cytokeratin 19, Thyroid Transcription Factor-1, and E-cadherin in Thyroid Carcinomas
por: Choi, Yoon-La, et al.
Publicado: (2005)

Combination of galectin-3, CK19 and HBME-1 immunostaining improves the diagnosis of thyroid cancer
por: Arcolia, Vanessa, et al.
Publicado: (2017)

Differential expression of galectin-3, CK19, HBME1, and Ret oncoprotein in the diagnosis of thyroid neoplasms by fine needle aspiration biopsy
por: Saleh, Husain A., et al.
Publicado: (2009)

The Combined Utility of HBME-1 and Galectin-3 Immunohistochemistry and BRAF V600E Mutations in the Diagnosis of Papillary Thyroid Carcinoma
por: Ramkumar, Subramaniam, et al.
Publicado: (2021)

HBME1 and CK19 expression in non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) vs other follicular patterned thyroid lesions
por: Sadiq, Qandeel, et al.
Publicado: (2021)

Galectin-3 and HBME-1 Expression on Agarose Cell Blocks from Fine-needle aspirates of Follicular Cell-derived Thyroid Tumors
por: Abu-Sinna, E., et al.
Publicado: (2018)

A Pilot Study of Galectin-3, HBME-1, and p27 Triple Immunostaining Pattern for Diagnosis of Indeterminate Thyroid Nodules in Cytology With Correlation to Histology
por: Zhang, Lei, et al.
Publicado: (2015)

Correlations Between Hector Battifora Mesothelial-1 (HBME-1) Expression and Clinical Pathological Characteristics and Prognosis of Osteosarcoma Patients
por: Zhao, Yu-Xin, et al.
Publicado: (2017)

Correlation between preoperative ultrasonic features of medullary thyroid carcinoma and postoperative recurrence
por: Zhu, Qiaodan, et al.
Publicado: (2021)

Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature
por: Dunđerović, Duško, et al.
Publicado: (2015)

Diagnostic Value of Galectin-3, HBME-1, Cytokeratin 19, High Molecular Weight Cytokeratin, Cyclin D1 and p27(kip1) in the Differential Diagnosis of Thyroid Nodules
por: Park, Young Joo, et al.
Publicado: (2007)

Unusual Clinical Manifestations of Thyroid Carcinoma
por: Brijmohan, Sharmela, et al.
Publicado: (2023)

Differentiated Thyroid Carcinoma: Distant Metastasis as an Unusual Sole Initial Manifestation
por: Dhanani, Rahim, et al.
Publicado: (2021)

Multimode ultrasonic technique is recommended for the differential diagnosis of thyroid cancer
por: Wang, Juan, et al.
Publicado: (2020)

The Expression of Twist in Differentiated Thyroid Carcinomas
por: CALANGIU, CRISTINA MARIANA, et al.
Publicado: (2014)

Expression of colorectal neoplasia differentially expressed in anaplastic thyroid carcinoma and its effect on cancer cell proliferation
por: Du, Lili, et al.
Publicado: (2022)

RET EXPRESSION AND ITS CORRELATION WITH CLINICOPATHOLOGIC DATA IN PAPILLARY THYROID CARCINOMA
por: Punda, Ante, et al.
Publicado: (2018)

Development and Validation of an Ultrasonic Diagnostic Model for Differentiating Follicular Thyroid Carcinoma from Follicular Adenoma
por: Huang, Qingshan, et al.
Publicado: (2021)

Oral manifestations of thyroid disorders and its management
por: Chandna, Shalu, et al.
Publicado: (2011)

Ultrasonic features of papillary thyroid microcarcinoma coexisting with a thyroid abnormality
por: Li, Bo, et al.
Publicado: (2016)

Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma
por: Teng, Lianghong, et al.
Publicado: (2017)

Ultrasonic Intelligent Diagnosis of Papillary Thyroid Carcinoma Based on Machine Learning
por: Zhou, Heng, et al.
Publicado: (2022)

Coexistence of Chronic Lymphocytic Thyroiditis with Papillary Thyroid Carcinoma: Clinical Manifestation and Prognostic Outcome
por: Jeong, Jun Soo, et al.
Publicado: (2012)

Identification of Biomarkers Based on Differentially Expressed Genes in Papillary Thyroid Carcinoma
por: Han, Jun, et al.
Publicado: (2018)

NKX2.5 is expressed in papillary thyroid carcinomas and regulates differentiation in thyroid cells
por: Penha, Ricardo Cortez Cardoso, et al.
Publicado: (2018)

RET/PTC and CK19 Expression in Papillary Thyroid Carcinoma and Its Clinicopathologic Correlation
por: Shin, Eunah, et al.
Publicado: (2005)

Etiopathogenesis of Differentiated Thyroid Carcinomas
por: Makazlieva, Tanja, et al.
Publicado: (2016)

Multicentricity in the thyroid differentiated carcinoma
por: Chagas, José Francisco Salles, et al.
Publicado: (2015)

Thyroiditis: A Rare Manifestation of Enasidenib-Induced Differentiation Syndrome
por: Annamaraju, Pavan, et al.
Publicado: (2020)

Neuropsychiatric Manifestations of Thyroid Diseases
por: Lekurwale, Vedant, et al.
Publicado: (2023)

Dataset of differential gene expression between total normal human thyroid and histologically normal thyroid adjacent to papillary thyroid carcinoma
por: Vitale, Lorenza, et al.
Publicado: (2019)

Cervical masses as manifestation of papillary thyroid carcinomas ≤10 mm in diameter, in patients with unknown thyroid disease
por: Pazaitou-Panayiotou, Kalliopi, et al.
Publicado: (2008)

Neoplastic pericarditis as the initial manifestation of a papillary thyroid carcinoma
por: Tsoukalas, Nikolaos, et al.
Publicado: (2013)

2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma
por: Lebbink, Chantal A, et al.
Publicado: (2022)

Thyroid functional parameters and correlative autoantibodies as prognostic factors for differentiated thyroid cancers
por: Li, Chao, et al.
Publicado: (2016)

Clinical study of ultrasonic evaluation of T/N staging of differentiated thyroid carcinoma using AJCC 8(th) staging criteria
por: Liang, Yu, et al.
Publicado: (2022)

Myocardial ultrasonic tissue characterization in patients with thyroid dysfunction
por: Romano, Minna MD, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_hs6iq27n8g9e3h74uq43dibbmu